Apeloa Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Apeloa Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Shandong Xinhua Pharmaceutical Company Limited
sales of 5.61 billion Chinese Renmimbi [US$800.65 million]
of which 57%
ChangChun High New Technology Industries
(7.27 billion Chinese Renmimbi [US$1.04 billion]
of which 88%
was Pharmaceutical Industry), and
Zhejiang Nhu Co Ltd
(7.62 billion Chinese Renmimbi [US$1.09 billion]
of which 94%
was Pharmaceutical Chemicals).
Apeloa Pharmaceutical Co Ltd reported sales of 7.21 billion Chinese Renmimbi (US$1.03 billion)
December of 2019.
increase of 13.1%
versus 2018, when the company's sales were 6.38 billion Chinese Renmimbi.
Sales at Apeloa Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 70%).
Sales of Healthcare and Pharmaceutical saw an increase
13.1% in 2019, from
6.36 billion Chinese Renmimbi to 7.20 billion Chinese Renmimbi.